Skip to content

AptarGroup

US · ATR #1713 by market cap Listed 1970
120.43 +0.18 +0.15%
Live - 5344 symbols - heartbeat 140s ago · 2026-10-08 08:16
Pre-market 120.70 +0.22%
After-hours 120.43 0.00%
Market cap
7.66B
P/B
2.91
EPS
5.89
Reader sentiment Are you bullish or bearish on ATR?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Below fair value
144.47 fair value ≈ 171.85 199.24
  • Implied fair-value range of 144.47-199.24, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -29.9% below the average-multiple fair value of 171.85.

Valuation each multiple against its own 5-year range

P/B ratio 2.90 Cheap vs history 5th percentile
5-year average 3.70 · #25 of 51 in Medical Instruments & Supplies
P/E ratio 21.63 Cheap vs history 11th percentile
5-year average 29.18 · forward 20.35 · #8 of 27 in Medical Instruments & Supplies
P/S ratio 1.94 Cheap vs history 4th percentile
5-year average 2.43 · forward 1.89 · #19 of 51 in Medical Instruments & Supplies

Vs. peers Medical Instruments & Supplies

Company Market cap P/E (TTM) P/B Div yield
AptarGroup (ATR) 7.66B 21.74 2.91 1.57%
Intuitive Surgical (ISRG) 146.44B 47.54 8.06 0.00%
Becton Dickinson & Co (BDX) 49.07B 54.43 2.01 2.33%
ResMed (RMD) 31.78B 21.67 4.83 1.06%
Medline (MDLN) 31.10B 67.27 2.69 0.00%
Alcon (ALC) 30.45B 48.09 1.41 0.56%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value144.56 Economic moatNarrow UncertaintyLow

Trading 20.0% below Morningstar's fair value estimate.

Fair value

AptarGroup Inc is assigned a 5-star quantitative star rating, indicating our belief that this share class offers a compelling opportunity for investors. The stock currently trades at a 17% discount to our quantitative fair value estimate of $144.56 per share, which is reinforced by this estimate's low uncertainty rating.

The company's profitability strengthens our estimated fair value. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. For example, the firm's enterprise value to free cash flow ratio of 18.4 lies in the bottom 40% globally. This can be a sign of operational efficiency and potential for the company to fund growth, pay dividends, or reduce debt without needing additional capital. We believe this is a sign that shares could be cheap.

On a different note, the company's balance sheet is potentially concerning. Excessive leverage heightens financial risk, potentially undermining a firm's value. The firm's EBITDA/interest coverage ratio of 12.8, for example, ranks in the bottom 50% globally. This gives us pause, as it can be a warning sign of financial distress if conditions don't improve. Despite our favorable price/fair value ratio, this characteristic is a negative attribute.

Economic moat

The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.

By Quantitative Equity Report

Quote time 2026-10-08 08:16:30 · For reference only, not investment advice and not tailored to your situation.